Optic nerve imaging in multiple sclerosis.
In this article I review the last 10 years of progress in the imaging of the optic nerve with a particular focus on applications to multiple sclerosis (MS). Development of magnetic resonance imaging (MRI) of the optic nerve has lagged behind imaging of other parts of the CNS. These limitations are due to technical challenges related to the small size and mobility of the optic nerves and artefacts caused by surrounding cerebrospinal fluid, orbital fat, and air-bone interfaces. Nonetheless the last 10 years has seen significant progress with regard to detecting optic nerve atrophy following optic neuritis, the use of fat- and CSF-suppressed high resolution imaging, the ability to measure magnetization transfer ratio and diffusivity in the optic nerve, and the emergence of SPIR-FLAIR for increasing sensitivity to inflammatory demyelination. Remaining challenges include further reduction of movement artifacts, testing ultra-high field MRI systems and dedicated surface coils, and developing automated segmentation techniques to improve the reproducibility of quantitative measurements. Finally the role of optic coherence tomography as a marker of retinal damage needs to be clarified further through correlations with MRI, clinical, and electrophysiologic data.
Hickman
Simon J
SJ
Department of Neurology, The Royal Hallamshire Hospital, Sheffield, UK. simon.hickman@sth.nhs.uk
D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009103:Multiple Sclerosis / Q000473:pathology*; D009896:Optic Atrophy / Q000473:pathology; D009900:Optic Nerve / Q000473:pathology*; D009902:Optic Neuritis / Q000473:pathology